AptaBio Therapeutics Inc banner
A

AptaBio Therapeutics Inc
KOSDAQ:293780

Watchlist Manager
AptaBio Therapeutics Inc
KOSDAQ:293780
Watchlist
Price: 6 420 KRW 0.31% Market Closed
Market Cap: ₩180.3B

Dividends

AptaBio Therapeutics Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for AptaBio Therapeutics Inc is .

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
AptaBio Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
AptaBio Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

Price
AptaBio Therapeutics Inc

Annual Price Range
6 420
52w Low
4 000
52w High
10 420
Price Metrics
Average Annual Return -36.58%
Standard Deviation of Annual Returns 25.07%
Max Drawdown -93%
Shares Statistics
Market Capitalization 180.4B KRW
Shares Outstanding 28 090 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

AptaBio Therapeutics Inc's latest stock split occurred on Aug 24, 2021

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, AptaBio Therapeutics Inc traded at 101300 per share. Afterward, the share price was about 47600.

The adjusted shares began trading on Aug 24, 2021. This was the only stock split in AptaBio Therapeutics Inc's history.

Pre-Split Price
50 650 101 300
Post-Split Price
47 600
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett